Skip to content
Life Sciences Series B Founded 2005

Proteon Pharmaceuticals

Developer of bacteriophage-based products for livestock farming and aquaculture health. The company provides solutions addressing protein production challenges, including gut health, antimicrobial resistance, and food safety. Its products modulate the microbiome, preventing gut dysbiosis and supporting the immune system. The company’s feed additives reduce the need for antibiotics and chemicals while improving food…

📍 Lodz, Poland · Genomics,

Funding snapshot

Last roundSeries B
Amount$25M
Date10 August 2021
Total raised$29M
Team size49

About

Developer of bacteriophage-based products for livestock farming and aquaculture health. The company provides solutions addressing protein production challenges, including gut health, antimicrobial resistance, and food safety. Its products modulate the microbiome, preventing gut dysbiosis and supporting the immune system. The company’s feed additives reduce the need for antibiotics and chemicals while improving food safety. Founded in 2005, headquartered in Lodz, Poland. The company operates in the Genomics sector with additional focus on Livestock Tech and Veterinary HealthTech. Its business model centers on Livestock. Founded in 2005, headquartered in Lodz, Poland. The company has raised $28.8M at the Series B stage. Backed by investors including Nutreco, Aqua Spark, Montis Capital, Seventure Partners, Bioinfo and others.

Business model

Veterinary HealthTech > Biopharmaceuticals > Livestock,

Genomics > Applied Genomics > Veterinary Genomics,

Livestock Tech > Health Management > Pharmaceuticals > Antibiotic Substitutes

Institutional investors

Nutreco Aqua Spark Montis Capital Seventure Partners Bioinfo PFR Group FPCI Alven Capital V Bengt Wahlqvist Matthew Tebeau

Latest coverage

No articles yet.

Raising like Proteon Pharmaceuticals?

Analyze your pitch deck before your next raise.

Analyze My Deck →